High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot studyRichard A. Nash, Daniel E. Furst, Maureen D. Mayes et al.|Blood|2007Cited by 264
Autologous hematopoietic cell transplantation following high-dose immunosuppressive therapy for advanced multiple sclerosis: long-term resultsJames D. Bowen, RA Nash, George H. Kraft et al.|Bone Marrow Transplantation|2011Cited by 82
Allogeneic marrow transplantation in patients with severe systemic sclerosis: Resolution of dermal fibrosisRichard A. Nash, Daniel E. Furst, Peter A. McSweeney et al.|Arthritis & Rheumatism|2006Cited by 76
High-Dose Immunosuppressive Therapy (HDIT) for Severe Systemic Sclerosis (SSc): Long-Term Survivors Show Continued Improvement of Function and Skin with Stability in the Lungs.Peter A. McSweeney, Richard A. Nash, Daniel E. Furst et al.|Blood|2004Cited by 3
Four-Year Follow-Up after High-Dose Immunosuppressive Therapy (HDIT) for Severe Systemic Sclerosis (SSc).Richard A. Nash, Daniel E. Furst, Peter A. McSweeney et al.|Blood|2006Cited by 0